Related Experiment Video
Updated: May 29, 2026
08:33
Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
The NS5A replication complex inhibitors: difference makers?
Robert G Gish1, Nicholas A Meanwell
1Division of Gastroenterology, University of California at San Diego, San Diego, CA 92103-8413, USA. rgish@ucsd.edu
Clinics in Liver Disease
|August 27, 2011
Summary
Novel direct-acting antivirals targeting the NS5A protein show promise for treating chronic hepatitis C. These NS5A replication complex inhibitors are effective across genotypes and rapidly suppress viral replication in early trials.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis C virus (HCV) infection is a significant global health concern.
- Direct-acting antiviral (DAA) agents represent a paradigm shift in HCV treatment.
- The NS5A protein is crucial for HCV replication, making it a key therapeutic target.
Purpose of the Study:
- To review the discovery and development of novel compounds inhibiting the NS5A protein.
- To highlight the role of NS5A replication complex inhibitors in HCV treatment.
Main Methods:
- Review of preclinical studies on NS5A inhibitors.
- Analysis of early phase clinical trial data for NS5A inhibitors.
- Summary of the development pipeline for these novel agents.
Main Results:
- NS5A inhibitors demonstrate potent antiviral activity across diverse HCV genotypes.
- These agents rapidly suppress viral replication in monotherapy and combination regimens.
- Early trials show efficacy when combined with pegylated interferon-alfa and ribavirin.
Conclusions:
- NS5A replication complex inhibitors are a promising class of drugs for chronic hepatitis C.
- These agents are poised to transform the treatment landscape for hepatitis C infection.
- Continued development of NS5A inhibitors offers new therapeutic options for patients.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
00:55DNA Helicases
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...